Fizjologiczne i żywieniowe znaczenie piwa

Kordialik-Bogacka, E.

Artykuł - szczegóły

Tytuł artykułu

Fizjologiczne i żywieniowe znaczenie piwa

Autorzy

Kordialik-Bogacka E.

Wybrane pełne teksty z tego czasopisma

Identyfikatory

Warianty tytułu

Physiological and nutritional value of beer

Języki publikacji

Abstrakty

W pracy dokonano przeglądu literatury dotyczącej aspektów prozdrowotnych piwa i przedstawiono w świetle najnowszych badań korzyści płynące z umiarkowanego spożywania piwa. Omówione zostały fizjologiczne i żywieniowe walory piwa. Opisano funkcjonalne właściwości poszczególnych składników piwa.

Recent fundamental research on health benefits of moderate consumption of beer is presented in this review. This article describes physiological and nutritional advantages of beer. Functional properties of beer components, such as water, alcohol, polyphenols, polysaccharides, nitrogenous compounds, vitamins and mineral compounds were shown.

Słowa kluczowe

piwo konsumpcja piwa alkohol napoje

beer beer consumption alcohol beverages

Wydawca

Wydawnictwo Politechniki Łódzkiej

Czasopismo

Zeszyty Naukowe. Chemia Spożywcza i Biotechnologia / Politechnika Łódzka

Rocznik

2005

Tom

Z. 69

Strony

105--121

Opis fizyczny

Bibliogr. 96 poz.

Twórcy

autor

Kordialik-Bogacka E.

Instytut Technologii Fermentacji i Mikrobiologii, Politechnika Łódzka

Bibliografia

[1] Arimoto-Kobayashi S., Sugiyama C, Harada N.: Inhibitory effects of beer and other alcoholic beverages on mutagenesis and DNA adduct formation inducted by several carcinogens. J. Agric. Food Chem. 47, 221-230, (1999).
[2] Back W., Franz O., Nakamura T.: Antioxidative potential of beer. Brauwelt International 20, 270-279, (2002).
[3] Bamforth C.W.: Nutritional aspects of beer - a review. Nutr. Res. 22, 227-237, (2002).
[4] Bell S., Goldman V.M., Bistrian B.R., Arnold A.H., Ostroff G., Forse R.A.: Effect of ß-glucan from oats and yeast on serum lipids. Crit. Rev. Food Sei. Nutr. 39, 189-202,(1999).
[5] Biendl M.: Estrogenic activity of hop components. Brauwelt International 22, 24- 28, (2004).
[6] Bobak M., Skodova Z., Marmot M.: Effect of beer drinking on risk of myocardial infarctionpopulation based case-control study. Brit. Med. J. 1378-1379, (2000).
[7] Bourne L., Paganga G., Baxter D., Hughes P., Rice-Evans C.: Absorption of ferulic acid from low-alcohol beer. Free Radie. Res. 32, 273-280, (2000).
[8] Brenner H., Rothenbacher D., Bode G., Adler G.: Inverse graded relation between alcohol consumption and active infection with Helicobacter pylori. Am. J. Epidemiol. 149, 571-576, (1999).
[9] Brenner H., Rothenbacher D., Bode G., Adler G.: Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infectioncross sectional study. Brit. Med. J. 1489-1492, (1997).
[10] Burke V., Puddey I.B., Beilin L.J.: Mortality associated with wines, beers and spirits. Brit. Med. J. 1166a, (1995).
[11] Carbonneau M.A., Leger C.L., Descomps B., Michel F., Monnier L.: Improvement in the antioxidant status of plasma and low-density lipoprotein in subjects receiving a red wine phenolics mixture. J. Am. Oil Chem. Soc. 75, 235- 240, (1998).
[12] Cestaro B., Simonetti P., Cervato G., Brusomolino A., Gatti P., Testolin G.: Red wine effects on peroxidation indices of rat plasma and erythrocytes. Intern. J. Food Sc. Nutr. 181-189, (1996).
[13] Charles P., Laitinen K., Kardinaal A.: Alcohol and Bone in Health Issues Related to Alcohol Consumption, 2nd ed., Ian Macdonald, Blackwell Science Ltd. 1999.
[14] Cleophas T. J.: Wine, beer, and spirits, and the risk of myocardial infarctiona systematic review. Biomed. Pharm. 417-423, (1999).
[15] Croft K.D., Puddey I.B., Rakic V., Abu-Amsha R., Dimmit S.B., Beilin L.J.: Oxidative susceptibility of low-density lipoproteins-influence of regular alcohol use. Alcohol Clin. Exp. Res. 980-984, (1996).
[16] Cupples L.A., Weinberg J., Beiser A., Auerbach S.H., Volicer L., Cipolloni P. B., Wells J., Growdon J.H., D’agostino R.B., Wolf P.A., Farrer L,A.: Effects of smoking, alcohol and APOE genotype on Alzheimer disease: The Mirage study. Alzheimer's Reports 3, 105-114, (2000).
[17] Doll R., Peto R., Hall E., Wheatley K., Gray R.: Mortality in relation to consumption of alcohol 13 years’ observations on male British doctors. Brit. Med. J. 911-918,(1994).
[18] Dufour M.C., Archer L., Gordis E.: Alcohol and the elderly. Clin. Ger. Med. 127- 141, (1992).
[19] Fagrell B., de Faire U., Bondy S., Criqui M., Gaziano M., Grønbæk M., Jackson R., Klatsky A., Salonen J., Shaper A.G.: The effects of light to moderate drinking oncardiovascular diseases. J. Intern. Med. 246, 331-340, (1999).
[20] Fantozzi P., Montanari L., Mancini F., Gasbarrini A., Addolorato G., Simoncini M., Nardini M., Ghiselli A., Scaccini C.: In vitro antioxidant capacity from wort to beer. Lebensm.-Wiss. u.- Technol. 31, 221-227, (1998).
[21] Farchi G., Fidanza F., Giampaoli S., Mariotti S., Menotti A.: Alcohol and survival in the Italian rural cohorts of the Seven Countries Study. Int. J. Epidemiol. 29, 667-671, (2000).
[22] Friedman L.A., Kinball A.W.: Coronary artery disease and alcohol consumption in Framingham. Am. J. Epidemiol. 481-489, (1986).
[23] Frimpong N.A., Lapp J.A.: Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men. Am. J. Clin. Nutr. 50, 987-991, (1989).
[24] Fuhrman D., Lavy A., Aviram M.: Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61, 549-554, (1995).
[25] Galobardes B., Morabia A., Bernstein M.S.: Diet and socioeconomic position does the use of different indicators matter? Int. J. Epidemiol. 334-340, (2001).
[26] Ghiselli A., Natella F., Guidi A., Montanari L., Fantozzi P., Scaccini C.: Beer increases plasma antioxidant capacity in humans. J. Nutr. Biochem. 11, 76-80, (2000).
[27] Gorinstein S., Caspi A., Libman I., Trakhtenberg S.: Cardioprotective effect of alcohol consumption: contemporary concepts. Nutr. Res. 22, 659-666, (2002).
[28] Gorinstein S., Caspi A., Zemser M., Trakhtenberg S.: Comparative contents of some phenolics in beer, red and white wines. Nutr. Res. 20, 131-139, (2000).
[29] Gorinstein S., Zemser M., Lichman I., Kleipfish A., Berebi A., Libman L, Trakhtenberg S., Caspi A.: Moderate beer consumption and the blood coagulation in patients with coronary artery disease. J. Intern. Med. 241, 47-51, (1997).
[30] Gorinstein S., Zemser M., Weisz M., Halevy S., Martin-Belloso O., Trakhtenberg S.: The influence of alcohol-containing and alcohol-free beverages on lipid levels and lipid peroxides in serum of rats. J. Nutr. Biochem. 9, 682-686, (1998).
[31] Gorinstein S., Zemser M., Weisz M., Haruenkit R., Trakhtenberg S.: The influence of dry matter of different alcoholic beverages on lipid and protein metabolism and antioxidant activity in serum of rats. J. Nutr. Biochem. 9, 131-135, (1998).
[32] Gromes R., Zeuch M., Piendl A.: Further investigations into the dietary fibre content of beers. Brauwelt International 18, 24-28, (2000).
[33] Halpern M.J., Dahlgren A.L., Laakso L, Seppanen-Laakso T., Dahlgren J., McAnulty P.A.: Red-wine polyphenols and inhibition of platelet aggregation - possible mechanisms and potential use in health promotion and disease prevention. J. Int. Med. Res. 26, 171-180, (1998).
[34] Hendriks H.F.J., Veenstra J., Velthuis-Te Wierik Shaafsma G., Kluft C.: Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Brit. Med. J. 1003-1006, (1994).
[35] Hirvonen T., Pietinen P., Virtanen M., Albanes D., Virtamo J.: Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am. J. Epidemiol. 150, 187-194, (1999).
[36] Hoffmeister H., Schelp F-Р., Mensink G.B.M., Dietz E., Bohning D.: The relationship between alcohol consumption, health indicators and mortality in the German population. Int. J. Epidemiol. 28,1066-1072, (1999).
[37] Hough J.S., Briggs D.E., Stevens R., Young T.W.: Hopped wort and beer. 2nd edn. vol. 2. Malting and Brewing Science. Chapman & Hall, London (1982).
[38] Hulley S.B., Gordon S.: Alcohol, and high density lipoprotein cholesterol. Causal inference from diverse study designs. Circulation 64, 57-63, (1981).
[39] Janssens J., Shapira N., Debeuf P., Michiels L., Putman R., Bruckers L., Renard D., Molenberghs G.: Effects of soft drink and table beer consumption on insulin response in teenagers. Eur. J. Cancer Prevention 8, 289-295, (1999).
[40] Jugdaohsingh R., Anderson S.H.C.: Tucker K.L.: Elliot H., Kiel D.P., Thompson R.P. H., Powell J.J.: Dietary silicon intake and absorption. Am. J. Clin. Nutr. 75, 887-893, (2002).
[41] Keil U., Chambless L.E., Doring A., Filipiak В., Stieber J.: The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer-drinking population. Epidemiology 8, 150-156, (1997).
[42] Kitagawa S., Kametani F., Tsuchiya K., Sakurai H.: ESR analysis with long- chain alkyl spin labels in bovine blood platelets. Relationship between the increase in membrane fluidity by alcohols and phenolic compounds and their inhibitory effects on aggregation. Biochim. Biophys. Acta 1027, 123-129, (1990).
[43] Klatsky A.L.: Moderate drinking, and reduced risk of heart disease. Ale. Res. Health 23, 15-23, (1999).
[44] Klatsky A.L., Armstrong M.A., Friedman G.D.: Red wine, white wine, liquor, beer and risk for coronary artery disease hospitalization. Am. J. Cardiol. 80, 416- 420, (1997).
[45] Klatsky A., Armstrong M.A., Friedman G.D.: Relations of alcohol beverage use to subsequent coronary artery disease hospitalization. Am. J. Cardiol. 58, 710-714, (1986).
[46] Krieger J.N., Kronmal R.A., Coxon V., Wortley P., Thompson L., Sherrard D.J.: Dietary and behavioural risk factors for urolithiasispotential implications for prevention. Am. J. Kidney Dis. 195-201, (1996).
[47] Kunze W.: Technologia piwa i słodu. Piwochmiel, Warszawa, (1999).
[48] Kuo S.M.: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110, 41-48, (1996).
[49] Lapcik O., Hill M., Hampl R., Wahała K., Adlercreutz H.: Identification of isoflavanoids in beer. Steroids 63, 14-20, (1998).
[50] Leger A.S., Cochrane A.L., Moore L: Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1, 1017-1020, (1979).
[51] Leitzmann M.F., Giovannucci E.L., Stampfer M.J., Spiegelman D., Colditz G. A., Willett W.C., Rimm E.B.: Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. J. Clin. Exp. Res. 23, 835-841,(1999).
[52] Marques-Vidal P., Cambou J.P., Nicaud V., Luc G., Evans A., Arveiler D., Bingham A., Cambien F.: Cardiovascular risk factors and alcohol consumption in France and northern Ireland. Atherosclerosis 115, 225-232, (1995).
[53] Masarei J.R., Puddey I.B., Rouse I.L., Lynch WJ., Vandongen R., Beilin L.J.: Effect of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. Atherosclerosis 60, 79-87, (1986).
[54] Mayer O., Simon J., Roslova H.: A population study of beer consumption on folate, and homocysteine concentrations. Eur. J. Clin. Nut. 605-609, (2001).
[55] McConnel M. V., Vavouranakis I., Wu L.L., Vaughan D.E., Ridker P.M.: Effects of a single daily alcoholic beverage on lipid and haemostatic markers of cardiovascular risk. Am. J. Cardiol. 80, 1226-1228 (1997).
[56] McMurrough I., Delcour J. A., Wort polyphenols. Ferment 3, 175-182, (1994).
[57] Miranda C.L., Stevens J.F., Helmrich A., Henderson M.C., Rodriguez R.J., Yang Y.H., Deinzer M.L., Barnes D.W., Buhler D.R.: Antiproliferative and cytotoxic effects of prenylated flavonoids from hops in human cancer cell lines. Food and Chemical Toxicology 37, 271-285, (1999).
[58] Miranda C.I., Stevens J.F., Willard C.: Antiproliferative and cytotoxic effects of xanthohumol in human prostate cancer cells. Toxicologist 48, 348, (1999).
[59] Morrell P.: Re - does copper in beer protect the heart? Brit. Med. J. 320, 1378- 1379 (2000).
[60] Mortensen E.L., Jensen H.H., Sanders S.A., Reinisch J. M.: Better psychological functioning and higher social status may largely explain the apparent health benefits of wine-a study of wine and beer drinking in young Danish adults. Arch. Int. Med. 161, 1844-1848,(2001).
[61] Mosinger B.: Polyphenolics but not alcohol in beer and wine protect serum low- density lipoprotein against atherogenic modification. Cor Vasa 171-174, (1994).
[62] Pace-Asciak C. R., Hahn S., Diamandis E. P., Soleas G., Goldberg D. M.: The red wine phenolics trans-resveretrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin. Chim. Acta 235, 207-219, (1995).
[63] Paganga G., Miller N., Rice-Evans C.A.: The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radie. Res. 30, 153-162, (1999).
[64] Piendl A.: Definitions of moderate alcohol consumption. Brauwelt International 17, 49-55, (1999).
[65] Piendl A.: Physiological effects of alcohol consumption. Brauwelt International 15, 310-319,(1997).
[66] Pohorecky L.A.: Interaction of alcohol and stress at the cardiovascular level. Alcohol 7, 537-541, (1990).
[67] Sripanyakorn S., Jugdaohsingh R., Elliott H., Walker C., Mehta P., Shoukru S., Thompson R.P.H., Powell J.J.: The silicon content of beer and its bioavailability in healthy volunteers. Brit. J. Nutr. 91, 403-409, (2004).
[68] Rapuri P.B., Gallagher J.C., Balhorn K.E., Ryschon K.L.: Alcohol intake and bone metabolism in elderly women. Am. J. Clin. Nutr. 72, 1206-1213, (2000).
[69] Rayman M. P.: The importance of selenium to human health. Lancet 356, 203-241, (2000).
[70] Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C.: Alcohol and platelet aggregationthe Caerphilly prospective heart disease study. Am. J. Clin. Nut. 1012-1017,(1992).
[71] Renaud S., de Lorgeril M.: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526, (1992).
[72] Ricken K.H.: Beer and health. Brauwelt International 21, 111-112, (2003).
[73] Rimm E.B., Klatsky A., Grobbe D., Stampfer M. J.: Review of moderate alcohol consumption and reduced risk of coronary heart diseaseis the effect due to beer, wine or spirit? Brit. Med. J. 731-736, (1996).
[74] Rimm E.B., Stampfer M.J., Colditz G.A., Willett W.C.: Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. Brit. Med. J. 310, 555-559, (1995).
[75] Rimm E.B., Willett W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., Hennekens C., Stampfer M.J.: Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J. Am. Med. Assoc. 279, 359-364, (1998).
[76] Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J.: Moderate alcohol intake and lower risk of coronary heart diseasemeta-analysis of effects on lipids and haemostatic factors. Brit. Med. J. 1523-1528, (1999).
[77] Satué-Gracia M.T., Andreas-Lacueva C., Lamuela-Raventos R.M., Frankel E.N.: Spanish sparking wines (Cavas) as inhibitors of in vitro human low-density lipoprotein oxidation. J. Agric. Food Chem. 2198-2202, (1999).
[78] Serafini M., Maiani G., Ferro-Luzzi A.: Alcohol free red wine enhances plasma antioxidant capacity in humans. J. Nutr. 128, 1003-1007, (1998).
[79] Shen F., Xue X., Weber G.: Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Research 19, 1657-1662, (1999).
[80] Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Arky R.A., Hennekens C.H., Speizer F.E.: A prospective study of moderate alcohol drinking and risk of diabetes in women. Am. J. Epidemiol. 128, 549-558, (1988).
[81] Suter P.M.: Effect of ethanol on energy expenditure. Am. J. Physiol. 226, 1204- 1212,(1994).
[82] Tagashira T., Watanabe M., Uematsu N,: Antioxidative activity of hop bitter acids and their analogues. Biosci. Biotech. Biochem. 59, 740, (1995).
[83] Tatsuta M., Iishi H., Baba M., Yano H., Uehara H., Nakaizumi A Attenuation by genistein of sodium-chloride-enhanced gastric carcinogens induced by N-methyl-Nl-nitro-N-nitrosoguanidine in Wistar rats. Int. J. Cancer 80, 396-399, (1999).
[84] Thornton J., Symes C., Heaton K.: Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 2, 819-822, (1983).
[85] Tjonneland A., Gronbaek M., Stripp C., Overvad K., Wine intake and diet in a random sample of 48763 Danish men and women. Am. J. Clin. Nut. 69, 49-54, (1999).
[86] Tobe H., Muraki Y., Kitamura K., Komiyama O., Sato Y., Sugioka T., Maruyama H.B., Matsuda E., Nagai M.: Bone resorption inhibitors from hop extract. Biosci. Biotech. Biochem. 61, 158-159, (1997).
[87] Tsumura K., Hayashi T., Suematsu C., Endo G., Fujii S., Okada K.: Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care 22, 1432-1437, (1999).
[88] Van der Gaag M.S., Ubbink J.B., Sillanaukee P., Nikkari S., Hendriks H.F.J.: Effect of consumption of red wine, spirits and beer on serum homocysteine. Lancet 355, 1522, (2000).
[89] Van der Gaag M.S., Van Tol A., Scheek L.M., James R.W., Urgert R., Schaafsma G., Hendriks H.F.J.: Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 147, 405-410, (1999).
[90] Walker C.: International Symposium Beer and Health Vienna. Brauwelt International 21, 250-251, (2003).
[91] Walker C.: The silicon content of German beers and its potential health implications. Brauwelt International 21, 173-174, (2003).
[92] Walker C.J.: Phytoestrogens in beer-good news or bad news? Brauwelt International 18, 38-39, (2000).
[93] Watten R.G.: Smokers and non-smokers differences in alcohol consumption and intake of other health-related substances in Norway -a general population study. Eur. J. Pub. Health 306-308, (1999).
[94] White I.R.: The cardioprotective effects of moderate alcohol consumption. Brit. Med. J. 1179-1180,(1996).
[95] Yin F., Giuliano A.E., Van Herle A.J.: Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 9, 369-376, (1999).
[96] Zhang S., Hunter D.J., Hankinson S.E., Giovannucci E.L., Rosner B.A., Colditz G.A., Speizer F.E., Willett W.C.: A prospective study of folate intake and the risk of breast cancer. J. Am. Med. Assoc. 281, 1632-1637, (1999).

Typ dokumentu

Bibliografia

Identyfikator YADDA

bwmeta1.element.baztech-article-LOD3-0010-0006